| Identification | Back Directory | [Name]
Eriocalyxin B | [CAS]
84745-95-9 | [Synonyms]
Eriocalyxin B
Kaura-2,16-diene-1,15-dione, 7,20-epoxy-6,7-dihydroxy-, (6β,7α)- | [Molecular Formula]
C20H24O5 | [MDL Number]
MFCD20260372 | [MOL File]
84745-95-9.mol | [Molecular Weight]
344.41 |
| Chemical Properties | Back Directory | [Boiling point ]
551.1±50.0 °C(Predicted) | [density ]
1.37±0.1 g/cm3(Predicted) | [storage temp. ]
4°C, protect from light | [form ]
Solid | [pka]
11.05±0.60(Predicted) | [color ]
White to off-white | [InChIKey]
RTIKCEKESDRWAE-HCLRZYKANA-N | [SMILES]
O[C@@]12OC[C@]3(C(C=CC(C)(C)[C@@]3([H])[C@@H]1O)=O)[C@]1([H])CC[C@@]3([H])C(=C)C(=O)[C@@]21C3 |&1:1,4,11,13,16,20,26,r| |
| Hazard Information | Back Directory | [Uses]
Eriocalyxin B is an ent-Kaurene diterpenoid isolated from Chinese herb Isodon eriocalyx. Eriocalyxin B has anti-cancer and anti-infammatory activities. Eriocalyxin B induces cell apoptosis[1]. | [References]
[1] Rong-Fang Mu, et al. Eriocalyxin B Inhibits Adipogenesis in 3T3-L1 Adipocytes by Cell Cycle Arrest. Nat Prod Bioprospect. 2020 Jun;10(3):131-140. DOI:10.1007/s13659-020-00240-6
[2] Wang WG, et al. Laxiflorolides A and B, epimeric bishomoditerpene lactones from Isodon eriocalyx. J Nat Prod. 2012 Jun 22;75(6):1102-7.
[3] Zhou X, et al. Eriocalyxin B, a novel autophagy inducer, exerts anti-tumor activity through the suppression of Akt/mTOR/p70S6K signaling pathway in breast cancer. Biochem Pharmacol. 2017 Oct 15;142:58-70.
[4] Lu Y, et al. Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells. Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2258-63.
[5] Leung CH, et al. Eriocalyxin B inhibits nuclear factor-kappaB activation by interfering with the binding of both p65 and p50 to the response element in a noncompetitive manner. Mol Pharmacol. 2006 Dec;70(6):1946-55.Leung CH, Grill SP, Lam W, Gao W, Sun HD, Cheng YC. Eriocalyxin B inhibits nuclear factor-kappaB activation by interfering with the binding of both p65 and p50 to the response element in a noncompetitive manner. Mol Pharmacol. 2006 Dec;70(6):1946-55. |
|
| Company Name: |
BioBioPha Co., Ltd. Gold
|
| Telephone: |
0871-65217109 |
| Website: |
http://www.biobiopha.com |
|